Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Volta Medical

AI Verdict

Tool A is a wearable cardioverter defibrillator designed for continuous patient monitoring and treatment of life-threatening arrhythmias in daily life. In contrast, Tool B is AI-powered software that assists electrophysiologists in real-time during cardiac ablation procedures for atrial fibrillation and tachycardia. While both utilize AI in cardiology, their distinct applications—out-of-hospital patient therapy versus in-procedure clinician support—make them suitable for different stages of cardiac care.

Choose Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) if…

Choose Jewel Patch Wearable Cardioverter Defibrillator (Jewel) if you require a discreet, highly compliant, and continuous solution for monitoring and treating life-threatening arrhythmias in an outpatient setting. This water-resistant, patch-based device is ideal for patients needing ongoing protection from sudden cardiac arrest outside of a hospital environment, offering both monitoring and therapy.

View Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) →

Choose VX1+ if…

Choose VX1+ if your electrophysiology team requires real-time, AI-powered assistance during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. This software is specifically designed to integrate with existing EP recording and 3D mapping systems to help identify abnormal electrograms, enhancing procedural guidance and efficiency in the cath lab.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) VX1+
Deployment Wearable device with mobile app Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Tool A, the Jewel Patch WCD, demonstrates superior patient usability with its high reported compliance (median wear time over 23 hours/day), water-resistant, and discreet design. These features enable continuous wear, including during daily activities like showering, which significantly enhances the patient experience and adherence to therapy.

Clinical Value

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Tool A offers direct, life-saving clinical value by continuously monitoring for and treating life-threatening arrhythmias, including successful termination of ventricular tachycardia/fibrillation. Its ability to deliver therapy for sudden cardiac arrest directly impacts patient survival.

Pricing & Value

Tie

Both Tool A and Tool B lack publicly available pricing information, requiring direct contact with the vendor. Without transparent pricing or specific cost-effectiveness studies for either product, it is impossible to conduct a meaningful comparison of their pricing and overall value.

Enterprise Readiness

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

While both tools have FDA clearance and are expected to be HIPAA compliant, Tool A presents a more comprehensive enterprise solution with its hardware device, associated mobile application, and cloud-based digital health platform. This integrated ecosystem is designed for managing patient data and remote monitoring at scale, and it is commercially available in limited U.S. markets.

Innovation

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Tool A represents a more disruptive innovation by transforming the traditional wearable cardioverter defibrillator into a discreet, patch-based, water-resistant device. This design, coupled with a machine learning algorithm, directly addresses long-standing challenges of patient compliance and comfort in a life-saving medical device category.

Support & Docs

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Element Science (Tool A) provides a more extensive and readily accessible suite of support documentation, including downloadable product manuals for both patients and physicians, and instructional videos covering device application, removal, notifications, and app usage. This public availability of detailed resources indicates a stronger commitment to user support.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) VX1+
Primary Function Wearable Cardioverter Defibrillator (P-WCD) for continuous heart monitoring and treatment of life-threatening arrhythmias. AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
Company Element Science, Inc. Volta Medical
Target Specialties Cardiology Cardiology
Key Feature: Arrhythmia Management Detects and treats specific life-threatening arrhythmias; continuous heart rhythm monitoring. Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures; provides cycle length estimation from electrograms.
Key Feature: Design/Wearability Patch-based, water-resistant design for continuous wear, including showering; discreet, under-clothing design. Non-sterile reusable medical device; simple user interface with color coding for electrogram dispersion.
Key Feature: AI/Algorithm Machine learning detection algorithm for arrhythmia detection. AI-driven insights to assist electrophysiologists during ablation procedures.

Videos

Demos, reviews, and walkthroughs featuring Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) and VX1+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) is designed for continuous heart monitoring and treatment of life-threatening arrhythmias in adult patients at risk of sudden cardiac arrest, particularly those not eligible for or choosing not to receive a traditional implantable defibrillator. VX1+ is AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation (AF) and atrial tachycardia (AT).
The Jewel Patch WCD is a hardware device with an associated mobile application and a cloud-based digital health platform. VX1+ is a software application that integrates with existing EP recording and 3D mapping systems, such as Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, and Abbott EnSite X 3D mapping system.
The Jewel Patch WCD continuously monitors the heart to detect and treat specific life-threatening arrhythmias, including ventricular tachycardia/ventricular fibrillation (VT/VF). VX1+ identifies spatio-temporal dispersed electrograms (DEs) during AF and AT procedures to assist electrophysiologists in locating heart regions for ablation.
The Jewel Patch WCD is a water-resistant, patch-based wearable cardioverter defibrillator that uses a machine learning algorithm for arrhythmia detection and treatment. VX1+ is an AI-powered software application that utilizes machine and deep learning algorithms to provide real-time insights and annotations during cardiac ablation procedures.
The Jewel Patch WCD offers continuous wear, including showering, with high patient compliance (median wear time over 23 hours/day) and provides near real-time therapy information to the medical team. VX1+ provides real-time manual or automatic annotation of 3D anatomical and electrical maps, identifies DEs, and includes a booster mode for increased sensitivity during AT or slow AF.
Data handling systems associated with the Jewel P-WCD, such as the Jewel Mobile App and ES Cloud, are expected to be HIPAA compliant to protect patient health information, and a Business Associate Agreement (BAA) is likely for these platforms. For VX1+, HIPAA compliance is expected for a medical device handling patient data in U.S. healthcare settings, and a BAA is also expected.
AI Tool Finder
AI-powered search. Results may not be comprehensive.